In the ever-evolving landscape of mergers and acquisitions (M&A), recent rulings from the Delaware Chancery Court underscore the necessity for M&A attorneys to adopt a more nuanced approach to handling fraud claims, particularly those involving buyers. Two landmark cases, Fortis Advisors LLC v. Johnson & Johnson and Cytotheryx Inc. v. Castle Creek Biosciences Inc., highlight the importance of addressing the potential for buyer fraud claims beyond the traditional scope of due diligence.
M&A transactions often involve complex dynamics and high stakes, leading to intricate fraud claims that can serve as significant legal precedents. Historically, fraud claims have primarily centered around allegations against sellers. However, as illustrated by the Fortis Advisors case, such claims are increasingly being directed at buyers. In Fortis Advisors, Johnson & Johnson faced allegations of making certain extracontractual assurances about earnout milestones that were integral to the deal, yet ultimately unachieved due to undisclosed risks.
Similarly, the Cytotheryx case underscores a pivotal challenge for buyers. Castle Creek Biosciences’ assurances about redeeming preferred stock were contested in court, with Cytotheryx pursuing extracontractual fraud claims when those assurances proved misleading. The rulings emphasized that integration clauses without explicit disclaimers of reliance were insufficient in barring such claims.
This shift in legal scrutiny necessitates that buyers meticulously evaluate their exposure to such claims. As noted by Russell Hedman and Adrienne Ellman from Hogan Lovells, the threshold for demonstrating fraud varies across jurisdictions, with Delaware law acknowledging reckless misrepresentation as a minimum standard of proof. This can potentially widen the scope for fraud claims against buyers.
For M&A attorneys, the key takeaway is the growing necessity for a balanced approach in transactions. This might include negotiating terms that ensure fraud disclaimers are reciprocal, thereby protecting both parties equally. Ignoring these elements may leave buyers vulnerable, especially when sellers negotiate for their own protections while advocating for expansive exclusions.
In conclusion, it is increasingly imperative for legal professionals engaged in M&A to revisit established negotiation strategies and include broader parameters for fraud liability. This not only aligns with the dictates of recent court decisions but also provides a more comprehensive risk management framework for high-stakes transactions. For more insights, consider reviewing the original article on Bloomberg Law.